The Role of Connexin32 in the Pathogenesis of CMTX
The Role of Connexin32 in the Pathogenesis of CMTX
批准号:
6982772
负责人:
STEVEN Simon Scherer
金额:
$36.76万
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-12-15 至 2006-11-30
关键词:
Schwann cellscell linegap junctionsgene expressiongene mutationgenetically modified animalshereditary motor and sensory neuropathyhuman genetic material taglaboratory mousemembrane channelsmolecular pathologymyelinationmyelinopathynorthern blottingspathologic processprotein biosynthesisprotein structure functionprotein transportsex linked traittissue /cell culture
中文摘要
描述(申请人提供):连接蛋白32(Cx 32)属于一种基因
一个至少有15个成员的家族(在哺乳动物中),所有成员都编码间隙连接
proteins.六个连接蛋白寡聚形成半通道(或连接子),
当与相邻膜上的另一半通道并置时形成通道。
间隙连接允许离子和小分子的扩散,通常具有
分子量小于1000 Da。单个半通道可由以下组成:
一个以上的连接蛋白(异型连接蛋白),和半通道组成的
不同的连接蛋白也可以形成通道(异型间隙连接)。中
在一系列的论文中,我和我的同事们研究了基因突变是如何发生的,
人Cx 32基因引起X连锁型腓骨肌萎缩症(CMTX)。
这是第二个最常见的形式遗传性脱髓鞘神经病(CMT
类型1),一个遗传异质性的群体,集体是其中最
常见的遗传性神经系统疾病我们是第一个证明
突变导致CMTX,Cx 32定位于切口和旁阳极
(雪旺细胞(SC)髓鞘的区域,其组成于
非致密髓鞘),并且SC髓鞘含有功能间隙
交叉点与此特别相关的是,一些突变会导致损失
或改变运输,使突变蛋白不能到达
细胞膜。在到达细胞膜的突变体中,有些未能到达细胞膜,
形成功能性间隙连接(沟通能力不足),而其他人则是
沟通能力。我们已经制造出表达野生型或
两个不同的突变体Cx 32等位基因,并发现这两个突变体的贩运,
蛋白质与转染细胞中的蛋白质相似。其中一个变种人,
Arg 142 Trp对野生型Cx 32具有显性负效应:
突变蛋白质“挂”在高尔基体,它也导致野生型蛋白质,
也在那里积累。这种竞争性更新的目标如下:(1)
以确定CMTX突变的影响是否是自主的,
髓鞘化雪旺细胞;(2)确定Cx 32突变体如何形成间隙
体外连接破坏髓鞘SC的功能;(3)确定
髓鞘形成SC是否表达其他连接蛋白以及其他连接蛋白是否可以
髓鞘SC中Cx 32的替代品。结果将阐明间隙如何
连接蛋白在髓鞘形成SC中组装并发挥功能,
CMTX分子病理生理学的基本信息,以及
阐明其他间隙连接蛋白的突变如何导致疾病。
英文摘要
DESCRIPTION (provided by the applicant): Connexin 32 (Cx32) belongs to a gene
family of at least 15 members (in mammals), all of which encode gap junction
proteins. Six connexins oligomerize to form a hemi-channel (or connexon), which
forms a channel when apposed to another hemi-channel on an adjacent membrane.
Gap junctions allow the diffusion of ions and small molecules, typically with a
molecular mass less than 1000 Da. Individual hemichannels can be composed of
more than one connexin (heterotypic connexons), and hemichannels composed of
different connexins can also form channels (heterotypic gap junctions). In a
series of papers, my colleagues and I have investigated how mutations in the
human Cx32 gene cause the X-linked form of Charcot-Marie-Tooth disease (CMTX).
This is the second most common form of inherited demyelinating neuropathy (CMT
type 1), a genetically heterogenous group that collectively is among the most
common inherited neurological diseases. We were the first to show that
mutations cause CMTX, that Cx32 is localized to incisures and paranodes
(regions of the Schwann cell (SC) myelin sheath that are composed on
non-compact myelin) and that the SC myelin sheath contains functional gap
junctions. Of particular relevance to this grant, some mutations result in loss
of the protein, or alter trafficking so that the mutant protein does not reach
the cell membrane. Of the mutants that reach the cell membrane, some fail to
form functional gap junctions (communication-incompetent), whereas others are
communication-competent. We have made transgenic mice that express wild type or
two different mutant Cx32 alleles and found that trafficking of the two mutant
proteins was similar to that in transfected cells. One of the mutants,
Arg142Trp, has a dominant-negative effect on wild type Cx32: not only does the
mutant protein "hang up" in the Golgi, it also causes the wild type protein to
accumulate there, too. The goals of this competing renewal are as follows: (1)
to determine whether the effects of CMTX mutations are autonomous to
myelinating Schwann cells; (2) to determine how Cx32 mutants that form gap
junctions in vitro disrupt the function of myelinating SC; (3) to determine
whether myelinating SC express other connexins and whether other connnexins can
substitute for Cx32 in myelinating SC. The results will elucidate how gap
junction proteins are assembled and function in myelinating SC, provide
fundamental information on the molecular pathophysiology of CMTX, and
illuminate how mutations in other gap junction proteins cause disease.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
A dominant connexin43 mutant does not have dominant effects on gap junction coupling in astrocytes.
显性 connexin43 突变体对星形胶质细胞中的间隙连接耦合不具有显性作用。
DOI:
10.1017/s1740925x11000019
发表时间:
2010
期刊:
Neuron glia biology
影响因子:
--
作者:
[Wasseff,Sameh, Abrams,CharlesK, Scherer,StevenS]
通讯作者:
Scherer,StevenS
Human oligodendrocytes express Cx31.3: function and interactions with Cx32 mutants.
人少突胶质细胞表达 Cx31.3:功能以及与 Cx32 突变体的相互作用。
DOI:
10.1016/j.nbd.2008.01.009
发表时间:
2008
期刊:
Neurobiology of disease
影响因子:
6.1
作者:
[Sargiannidou,Irene, Ahn,Meejin, Enriquez,AlanD, Peinado,Alejandro, Reynolds,Richard, Abrams,Charles, Scherer,StevenS, Kleopa,KleopasA]
通讯作者:
Kleopa,KleopasA
DOI:
10.1016/j.nbd.2015.05.018
发表时间:
2015-10
期刊:
Neurobiology of disease
影响因子:
6.1
作者:
[Wasseff SK, Scherer SS]
通讯作者:
Scherer SS
Autoimmune Mechanisms in Peripheral Neuropathy
-
批准号:10239173
-
项目类别:
-
资助金额:$49.67万
-
财政年份:2018
-
负责人:STEVEN Simon Scherer
-
依托单位:
Autoimmune Mechanisms in Peripheral Neuropathy
-
批准号:9792291
-
项目类别:
-
资助金额:$50.77万
-
财政年份:2018
-
负责人:STEVEN Simon Scherer
-
依托单位:
How do dominant PMP2 mutations cause demyelinating neuropathy?
-
批准号:9437210
-
项目类别:
-
资助金额:$20.13万
-
财政年份:2017
-
负责人:STEVEN Simon Scherer
-
依托单位:
How do dominant PMP2 mutations cause demyelinating neuropathy?
-
批准号:9572452
-
项目类别:
-
资助金额:$24.15万
-
财政年份:2017
-
负责人:STEVEN Simon Scherer
-
依托单位:
A website for the inherited neuropathies
-
批准号:7942663
-
项目类别:
-
资助金额:$16.35万
-
财政年份:2009
-
负责人:STEVEN Simon Scherer
-
依托单位:
The Role of Connexin32 in the Pathogensis of CMTX
-
批准号:8337714
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
The Role of Connexin32 in the Pathogensis of CMTX
-
批准号:8186867
-
项目类别:
-
资助金额:$35.0万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
The Role of Connexin32 in the Pathogensis of CMTX
-
批准号:8732705
-
项目类别:
-
资助金额:$34.65万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
The role of connexin32 in the pathogenesis of CMTX
-
批准号:7213822
-
项目类别:
-
资助金额:$30.84万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
The role of connexin32 in the pathogenesis of CMTX
-
批准号:7342822
-
项目类别:
-
资助金额:$28.41万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
The role of connexin32 in the pathogenesis of CMTX
-
批准号:7730833
-
项目类别:
-
资助金额:$28.22万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
The Role of Connexin32 in the Pathogensis of CMTX
-
批准号:8534290
-
项目类别:
-
资助金额:$33.78万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
The role of connexin32 in the pathogenesis of CMTX
-
批准号:7537167
-
项目类别:
-
资助金额:$27.68万
-
财政年份:2007
-
负责人:STEVEN Simon Scherer
-
依托单位:
Axonal Injury in Demyelinating Disease
-
批准号:6457608
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2002
-
负责人:STEVEN Simon Scherer
-
依托单位:
Axonal Injury in Demyelinating Disease
-
批准号:6725327
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2002
-
负责人:STEVEN Simon Scherer
-
依托单位:
Axonal Injury in Demyelinating Disease
-
批准号:6872944
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2002
-
负责人:STEVEN Simon Scherer
-
依托单位:
Axonal alterations in demyelinating diseases
-
批准号:7342820
-
项目类别:
-
资助金额:$34.45万
-
财政年份:2002
-
负责人:STEVEN Simon Scherer
-
依托单位:
Axonal alterations in demyelinating diseases
-
批准号:8013782
-
项目类别:
-
资助金额:$33.76万
-
财政年份:2002
-
负责人:STEVEN Simon Scherer
-
依托单位:
Axonal Injury in Demyelinating Disease
-
批准号:6622836
-
项目类别:
-
资助金额:$33.88万
-
财政年份:2002
-
负责人:STEVEN Simon Scherer
-
依托单位:
Axonal alterations in demyelinating diseases
-
批准号:7212934
-
项目类别:
-
资助金额:$34.39万
-
财政年份:2002
-
负责人:STEVEN Simon Scherer
-
依托单位:
海外基金